ArTS Archivio della ricerca di Trieste

MARZARI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.942
EU - Europa 16.234
AS - Asia 15.174
SA - Sud America 5.012
AF - Africa 586
OC - Oceania 396
Continente sconosciuto - Info sul continente non disponibili 208
Totale 62.552
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.920
CN - Cina 5.496
IT - Italia 4.682
BR - Brasile 2.955
SG - Singapore 1.632
ES - Italia 1.577
DE - Germania 1.437
MX - Messico 1.280
GB - Regno Unito 1.183
JP - Giappone 1.157
IN - India 1.073
FR - Francia 1.060
TR - Turchia 1.007
SE - Svezia 800
ID - Indonesia 765
HK - Hong Kong 700
UA - Ucraina 693
VN - Vietnam 692
PL - Polonia 605
KR - Corea 564
NL - Olanda 512
CA - Canada 503
CO - Colombia 488
PT - Portogallo 464
AR - Argentina 447
TW - Taiwan 446
FI - Finlandia 413
PE - Perù 384
RU - Federazione Russa 378
CL - Cile 348
GR - Grecia 346
AU - Australia 330
AT - Austria 261
CH - Svizzera 256
TH - Thailandia 256
BE - Belgio 218
EC - Ecuador 217
RO - Romania 196
IE - Irlanda 186
SA - Arabia Saudita 177
DK - Danimarca 165
PK - Pakistan 154
EG - Egitto 144
IR - Iran 134
BD - Bangladesh 127
BG - Bulgaria 125
IL - Israele 111
CZ - Repubblica Ceca 102
MY - Malesia 98
HU - Ungheria 89
MA - Marocco 87
PH - Filippine 83
ZA - Sudafrica 81
HR - Croazia 73
SI - Slovenia 70
RS - Serbia 68
IQ - Iraq 66
NZ - Nuova Zelanda 62
VE - Venezuela 61
TN - Tunisia 56
NO - Norvegia 50
LB - Libano 49
LT - Lituania 49
LV - Lettonia 49
PA - Panama 44
JO - Giordania 42
UY - Uruguay 38
AE - Emirati Arabi Uniti 37
BO - Bolivia 37
CR - Costa Rica 37
GT - Guatemala 37
KZ - Kazakistan 37
SK - Slovacchia (Repubblica Slovacca) 34
DZ - Algeria 31
NG - Nigeria 31
PY - Paraguay 30
UZ - Uzbekistan 27
QA - Qatar 26
HN - Honduras 24
LK - Sri Lanka 23
PS - Palestinian Territory 23
NP - Nepal 22
SY - Repubblica araba siriana 21
BY - Bielorussia 20
KE - Kenya 20
CY - Cipro 18
DO - Repubblica Dominicana 18
ET - Etiopia 16
GE - Georgia 16
EE - Estonia 15
EU - Europa 15
NI - Nicaragua 15
OM - Oman 15
PR - Porto Rico 15
AZ - Azerbaigian 12
KW - Kuwait 12
LY - Libia 12
BA - Bosnia-Erzegovina 11
RE - Reunion 11
CD - Congo 10
Totale 62.109
Salva come PNG Salva come JPEG
Città #
Ashburn 9.001
Woodbridge 1.043
Ann Arbor 1.026
Germantown 1.013
Singapore 997
Houston 958
Fairfield 831
Milan 639
Beijing 603
Jacksonville 565
San Jose 553
Rome 538
São Paulo 509
Chandler 495
Hong Kong 409
Madrid 408
Wilmington 408
Seattle 388
Shanghai 356
Trieste 347
Guangzhou 346
Hefei 338
Seoul 316
Cambridge 309
Tokyo 302
Istanbul 301
Los Angeles 281
Dallas 267
Chicago 265
Lima 249
Barcelona 248
Rio de Janeiro 246
Paris 240
Council Bluffs 236
Ho Chi Minh City 230
Munich 219
Bogotá 211
Columbus 208
Hangzhou 208
Princeton 198
Frankfurt am Main 197
New York 194
Boardman 188
Hanoi 185
Athens 183
Santiago 183
Buenos Aires 179
Taipei 179
Izmir 170
Jakarta 169
Lisbon 168
Dublin 166
Moscow 155
Warsaw 155
Naples 154
Vienna 154
Ankara 153
Helsinki 151
Chengdu 146
Turin 141
Bangkok 137
Bologna 134
Bengaluru 133
Florence 128
The Dalles 128
Amsterdam 126
London 126
Nanjing 115
Curitiba 112
Brasília 110
Sofia 108
Berlin 104
Hyderabad 104
Medellín 104
Chennai 101
Melbourne 100
Mumbai 100
Valencia 98
Las Vegas 97
Zurich 97
Santa Clara 96
Zgierz 93
Toronto 92
Wuhan 92
Copenhagen 89
Lauterbourg 89
Sydney 89
Verona 88
Guadalajara 87
Thessaloniki 87
Buffalo 86
Goiânia 86
Porto 86
Quito 86
Washington 86
Benito Juarez 85
Porto Alegre 85
Boston 84
Brussels 82
Belo Horizonte 80
Totale 33.685
Salva come PNG Salva come JPEG
Nome #
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 44.818
Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats. 322
A reliable screening procedure for coeliac disease in clinical practice. 312
Anti transglutaminase antibodies cause ataxia in mice. 312
Anti-transglutaminase antibodies and age. 308
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 303
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 296
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 296
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 257
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 256
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 253
Using archaeal histones for precise DNA fragmentation , 20: 267-271 (2007) 252
Comparison of multiple forms of the high mobility group I proteins in rodent and human cells. Identification of human high mobility group I-C protein 248
Dual sugar gut-permeability testing on blood drop in animal models. 244
Autoantibodies as predictors of disease. 242
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 240
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 240
The gut as site of production of autoimmune antibodies. 236
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 234
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab. 234
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 231
Anti-transglutaminase and age, Clinical Chemestry 227
Anti-alpha enolase autoantibodies in coeliac disease 226
Anti tTG autoantibodies crossreacting with brain structures are produced in the intestine in celiac patient with equilibrium disorder 225
Anti-idiotypic response in mice expressing human autoantibodies. 223
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 215
Antibodies against breain structures in a celiac patient with ataxic syndrome are produced in the intestine 215
Antibodies in proteomics I: generating antibodies 213
Development of a novel rapid non-invasive screening test for coeliac disease. 213
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. 207
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 205
Gluten ataxia: passive transfer in a mouse model. 205
A zonulin-occludens toxin synthetic esapeptide modifies the intestinal permeabilità in in-vivo animal model 205
"Recombinant antibodies against human type ii transglutaminase and uses thereof" 199
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 198
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 196
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 194
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 191
Protective role of anti-idiotypic network in celiac disease prone subjects 190
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 189
A method for selecting phage display open reading frames on phages 185
Charecterization of tissue transglutaminase auto-antigenic response using cloned structural domains 185
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 184
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 183
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 183
Profiling the Autoantibody Repertoire by Screening Phage-Displayed Human cDNA Libraries 182
Site of syntesis of antibodies to A-gliadin and tissue-transglutaminase in celiac disease patients 180
Profiling celiac disease antibody repertoire 179
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 179
Protective role of anti-idiotypic network in celiac disease prone subjects 178
Rapid characterization of VH-5 family specific anti-tTG intestinal antibodies in celiac and autoimmune patients 178
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 175
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal-mucosa anti-transglutaminase antibodies 175
Antibodies anti-c5 component of the complement system and their use 174
Antibody library selection by the {beta}-lactamase protein fragment complementation assay 174
A rat atlas to characterise anti brain humoral resoponse in patients with gluten sensitivity and celiac disease 171
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. 169
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 166
Protective role of anti-idiotypic network in celiac disease prone subjects 163
null 163
Phage display of Bacillus thuringiensis CryIA(a) insecticidal protein 161
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 161
Characterizing monoclonal antibody epitopes by filtered gene fragment phagedisplay. 160
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies 159
Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet 158
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 152
Patterning of fibronectin using laser writer for force measurement in cells 152
Simple scale-up of recombinant antibody production using an UCOE containing vector 151
Antibodies in proteomics 151
J Pediatr Gastroenterol Nutr 1990 Oct;11(3):337-41 A dot immunobinding assay to detect anti-alpha-gliadin antibodies in celiac disease. 150
“Impianto di cellule epiteliali amniotiche umane crioconservate in un soggetto affetto da malattia di Niemann-Pick tipo B.” 149
RECOMBINANT ANTIBODIES AGAINST CD55 AND CD59 AND USES THEREOF 149
Immunochemical characterisation of a murine monoclonal anti-idiotypic antibody 143
Serum immunoglobulin A and G, and monoclonal antibodies anti-tissue transglutaminase from coeliac patients inhibit the catalytic activity both in vitro and in situ 138
Small, antibacterial and large, inactive peptides of neutrophil granules share immunoreactivity to a monoclonal antibody. 138
Human monoclonal anti-transglutaminase antibodies from celiac patients inhibit cell induced apoptosis 136
Malattia celiaca: tra passato e futuro 132
Expression of a cloned Bacillus thuringiensis delta-endotoxin gene in Bacillus subtilis 130
Identification of new antigen candidate of Multiple Sclerosis using an ORF selected phage display library 125
Human tissue transglutaminase ELISA: a powerful mass screening diagnostic assay for symptomatic and asymptomatic celiac disease. 122
Coeliac disease risk in patients with idiopathic dilated cardiomiopathy 121
Serum IgA and IgG and intestinal monoclonal anti-tissue transglutaminase antibodies from coeliac patients inhibit the catalytic activity both in vitro and in situ 120
null 119
Correlation between anti-transglutaminase antibodies and healthy status in the general population 117
Salivary anti-human transglutaminase in the diagnosis of coeliac disease 117
Filtering out open reading frames 114
Intestinal mucosa anti-transglutaminase antibodies in early stage of gluten intolerance 114
Identification of novel celiac disease autoantigens by combined phage display and protein array technology 112
Creation of a mouse model of coeliac disease by in vivo long term expression of disease specific anti trasnglutaminase antibody 110
Monoclonal anti-transglutaminase antibodies from celiac disease patients inhibit cell-induced apoptosis 110
Phage antibody library from celiac disease patient. 109
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 108
null 100
null 97
Rapid interactome profiling by massive sequencing 90
Oral mucosa precedes the intestine on the gluten-dependent immune response 86
Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies 81
Selecting Open Reading Frames from DNA 79
Predicting antigenic peptides suitable for the selection of phage antibodies 73
Molecular dissection of the tissue transglutaminase antoantibody response in celiac disease 62
Totale 62.552
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.515
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022948 0 0 36 113 47 101 45 37 122 103 92 252
2022/20231.484 167 199 112 212 172 272 2 113 159 8 51 17
2023/2024770 50 61 41 76 83 70 114 145 8 7 56 59
2024/202520.332 15 60 152 166 256 215 136 103 274 178 5.855 12.922
2025/202630.852 5.562 4.932 5.587 5.172 4.919 2.253 653 186 593 633 182 180
2026/2027659 170 273 216 0 0 0 0 0 0 0 0 0
Totale 62.552